Connection

Fuling Zhou to Carcinoma, Hepatocellular

Back to Details
This is a "connection" page, showing publications Fuling Zhou has written about Carcinoma, Hepatocellular.
Fuling Zhou
Connection Strength
0.249
Carcinoma, Hepatocellular
  1. Novel tumor suppressor SPRYD4 inhibits tumor progression in hepatocellular carcinoma by inducing apoptotic cell death. Cell Oncol (Dordr). 2019 Feb; 42(1):55-66.
    View in: PubMed
    Score: 0.090
  2. T Cell-Associated Immunotherapy for Hepatocellular Carcinoma. Cell Physiol Biochem. 2017; 41(2):609-622.
    View in: PubMed
    Score: 0.080
  3. Human Endogenous Retroviruses-K (HML-2) Expression Is Correlated with Prognosis and Progress of Hepatocellular Carcinoma. Biomed Res Int. 2016; 2016:8201642.
    View in: PubMed
    Score: 0.079
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.